We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NZ Industry Flinches at Fees in Trans-Tasman Regulatory System
NZ Industry Flinches at Fees in Trans-Tasman Regulatory System
Kiwi devicemakers are crying foul over proposed fee structures for the Australia New Zealand Therapeutic Products Agency (ANZTPA), saying they will stifle innovation among smaller medtech companies and limit access to new technologies.